SUPRIYA — Supriya Lifescience Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Supriya Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,300	4,609	5,704	6,965	8,279
Cost of Revenue
Gross Profit	3,163	2,540	3,129	4,480	5,290
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,257	3,438	4,132	4,561	5,627
Operating Profit	2,043	1,172	1,572	2,404	2,652
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,072	1,235	1,657	2,485	2,748
Provision for Income Taxes
Net Income After Taxes	1,518	899	1,191	1,880	2,091
Net Income Before Extraordinary Items
Net Income	1,518	899	1,191	1,880	2,091
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,518	899	1,191	1,880	2,091
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	18.8	11.8	15.4	24.2	27.1
Dividends per Share